págs. 2049-2051
págs. 2051-2052
págs. 2053-2053
págs. 2053-2053
págs. 2053-2053
págs. 2054-2054
págs. 2054-2054
págs. 2054-2054
Beyond Medication Reconciliation: The Correct Medication List
págs. 2057-2058
págs. 2059-2060
Single IRBs in Multisite Trials: Questions Posed by the New NIH Policy
págs. 2061-2062
págs. 2063-2064
págs. 2065-2066
Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab
págs. 2067-2069
Empirical MRSA Coverage for Nonpurulent Cellulitis: Swinging the Pendulum Away From Routine Use
págs. 2070-2071
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial
págs. 2072-2087
Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial
págs. 2088-2096
Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial
págs. 2097-2104
págs. 2105-2113
págs. 2114-2122
págs. 2123-2124
págs. 2125-2126
págs. 2128-2129
págs. 2129-2130
págs. 2131-2132
págs. 2132-2132
págs. 2132-2133
págs. 2133-2133
págs. 2133-2134
págs. 2142-2142
© 2001-2025 Fundación Dialnet · Todos los derechos reservados